Akiko Futamura
Amministratore Delegato presso Hinge Therapeutics, Inc.
Profilo
Akiko Futamura is currently the President & Chief Executive Officer at Hinge Therapeutics, Inc. Prior to this, she was the President & Director at CarnaBio USA, Inc.
Posizioni attive di Akiko Futamura
Società | Posizione | Inizio |
---|---|---|
Hinge Therapeutics, Inc.
Hinge Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Hinge Therapeutics, Inc. is an early-stage biopharmaceutical company based in Torrance, CA. The private company focuses on developing small-molecule therapeutics against traditionally undruggable/challenging targets for unmet medical needs. The company's proprietary technology, the Hinge drug discovery platform, has generated several novel inactivators against targets which are traditionally targeted only by large molecules such as antibody and siRNA. The current areas of interest include bleeding disorders, solid tumors, cardiovascular diseases, CNS, rare disease, and anti-aging. Hinge Therapeutics is seeking investors/partners who can help them advance their programs while further establishing their "Hinge drug discovery platform" which can be applied to many other challenging targets. The company was founded by Yoshihiko Futamura, and the CEO is Akiko Futamura. | Amministratore Delegato | - |
Precedenti posizioni note di Akiko Futamura
Società | Posizione | Fine |
---|---|---|
CarnaBio USA, Inc.
CarnaBio USA, Inc. Medical DistributorsDistribution Services CarnaBio USA, Inc. provides biologicals and allied products. The company is headquartered in Natick, MA. | Presidente | 01/02/2019 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
CarnaBio USA, Inc.
CarnaBio USA, Inc. Medical DistributorsDistribution Services CarnaBio USA, Inc. provides biologicals and allied products. The company is headquartered in Natick, MA. | Distribution Services |
Hinge Therapeutics, Inc.
Hinge Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Hinge Therapeutics, Inc. is an early-stage biopharmaceutical company based in Torrance, CA. The private company focuses on developing small-molecule therapeutics against traditionally undruggable/challenging targets for unmet medical needs. The company's proprietary technology, the Hinge drug discovery platform, has generated several novel inactivators against targets which are traditionally targeted only by large molecules such as antibody and siRNA. The current areas of interest include bleeding disorders, solid tumors, cardiovascular diseases, CNS, rare disease, and anti-aging. Hinge Therapeutics is seeking investors/partners who can help them advance their programs while further establishing their "Hinge drug discovery platform" which can be applied to many other challenging targets. The company was founded by Yoshihiko Futamura, and the CEO is Akiko Futamura. | Health Technology |
- Borsa valori
- Insiders
- Akiko Futamura